142 related articles for article (PubMed ID: 11289571)
1. Vasomax for the treatment of male erectile dysfunction.
Goldstein I; Carson C; Rosen R; Islam A
World J Urol; 2001 Feb; 19(1):51-6. PubMed ID: 11289571
[TBL] [Abstract][Full Text] [Related]
2. Oral phentolamine: an alpha-1, alpha-2 adrenergic antagonist for the treatment of erectile dysfunction.
Goldstein I
Int J Impot Res; 2000 Mar; 12 Suppl 1():S75-80. PubMed ID: 10845768
[TBL] [Abstract][Full Text] [Related]
3. Long-term safety and efficacy of oral phentolamine mesylate (Vasomax) in men with mild to moderate erectile dysfunction.
Padma-Nathan H; Goldstein I; Klimberg I; Coogan C; Auerbach S; Lammers P;
Int J Impot Res; 2002 Aug; 14(4):266-70. PubMed ID: 12152116
[TBL] [Abstract][Full Text] [Related]
4. Oral phentolamine: an alpha-1, alpha-2 adrenergic antagonist for the treatment of erectile dysfunction.
Goldstein I
Int J Impot Res; 2000 Mar; 12(S1):S75-S80. PubMed ID: 10849569
[TBL] [Abstract][Full Text] [Related]
5. Phentolamine mesylate relaxes penile corpus cavernosum tissue by adrenergic and non-adrenergic mechanisms.
Traish A; Gupta S; Gallant C; Huang YH; Goldstein I
Int J Impot Res; 1998 Dec; 10(4):215-23. PubMed ID: 9884917
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the efficacy and safety of sildenafil citrate (Viagra) and oral phentolamine for the treatment of erectile dysfunction.
Ugarte F; Hurtado-Coll A
Int J Impot Res; 2002 Aug; 14 Suppl 2():S48-53. PubMed ID: 12161768
[TBL] [Abstract][Full Text] [Related]
7. Effects of oral phentolamine, taken before sleep, on nocturnal erectile activity: a double-blind, placebo-controlled, crossover study.
Hatzichristou DG; Apostolidis A; Tzortzis V; Hatzimouratidis K; Kouvelas D
Int J Impot Res; 2001 Oct; 13(5):303-8. PubMed ID: 11890519
[TBL] [Abstract][Full Text] [Related]
8. Combination therapy for erectile dysfunction: a randomized, double blind, unblinded active-controlled, cross-over study of the pharmacodynamics and safety of combined oral formulations of apomorphine hydrochloride, phentolamine mesylate and papaverine hydrochloride in men with moderate to severe erectile dysfunction.
Lammers PI; Rubio-Aurioles E; Castell R; Castaneda J; Ponce de Leon R; Hurley D; Lipezker M; Loehr LA; Lowrey F
Int J Impot Res; 2002 Feb; 14(1):54-9; discussion 60. PubMed ID: 11896479
[TBL] [Abstract][Full Text] [Related]
9. Alpha-adrenergic receptor blockade by phentolamine increases the efficacy of vasodilators in penile corpus cavernosum.
Kim NN; Goldstein I; Moreland RB; Traish AM
Int J Impot Res; 2000 Mar; 12 Suppl 1():S26-36. PubMed ID: 10845762
[TBL] [Abstract][Full Text] [Related]
10. The etiology of erectile dysfunction and mechanisms by which drugs improve erection.
Gallé G; Trummer H
Drugs Today (Barc); 2003 Mar; 39(3):193-202. PubMed ID: 12730703
[TBL] [Abstract][Full Text] [Related]
11. α
Martínez-Salamanca JI; La Fuente JM; Martínez-Salamanca E; Fernández A; Pepe-Cardoso AJ; Louro N; Carballido J; Angulo J
J Sex Med; 2016 Dec; 13(12):1844-1857. PubMed ID: 27864032
[TBL] [Abstract][Full Text] [Related]
12. Oral phentolamine (Vasomax).
Brock G
Drugs Today (Barc); 2000; 36(2-3):121-4. PubMed ID: 12879109
[TBL] [Abstract][Full Text] [Related]
13. New treatment options for erectile dysfunction in patients with diabetes mellitus.
Basu A; Ryder RE
Drugs; 2004; 64(23):2667-88. PubMed ID: 15537369
[TBL] [Abstract][Full Text] [Related]
14. Sildenafil: a review of its use in erectile dysfunction.
Langtry HD; Markham A
Drugs; 1999 Jun; 57(6):967-89. PubMed ID: 10400408
[TBL] [Abstract][Full Text] [Related]
15. Pilot study of the endothelin-A receptor selective antagonist BMS-193884 for the treatment of erectile dysfunction.
Kim NN; Dhir V; Azadzoi KM; Traish AM; Flaherty E; Goldstein I
J Androl; 2002; 23(1):76-83. PubMed ID: 11780926
[TBL] [Abstract][Full Text] [Related]
16. Oral alpha adrenoceptor blockade as a treatment of erectile dysfunction.
Andersson KE; Stief C
World J Urol; 2001 Feb; 19(1):9-13. PubMed ID: 11289574
[TBL] [Abstract][Full Text] [Related]
17. Determinants of satisfactory rigidity after intracavernosal injection with prostaglandin E1 in men with erectile failure.
Purvis K; Brekke I; Christiansen E
Int J Impot Res; 1996 Mar; 8(1):9-16. PubMed ID: 8735188
[TBL] [Abstract][Full Text] [Related]
18. Experience with buccal phentolamine mesylate for impotence.
Zorgniotti AW
Int J Impot Res; 1994 Mar; 6(1):37-41. PubMed ID: 7517275
[TBL] [Abstract][Full Text] [Related]
19. Penile erection and cardiac risk: pathophysiologic and pharmacologic mechanisms.
Andersson K; Stief C
Am J Cardiol; 2000 Jul; 86(2A):23F-26F. PubMed ID: 10899273
[TBL] [Abstract][Full Text] [Related]
20. An open-label, uncontrolled dose-optimization study of sublingual apomorphine in erectile dysfunction.
Mulhall JP; Bukofzer S; Edmonds AL; George M;
Clin Ther; 2001 Aug; 23(8):1260-71. PubMed ID: 11558862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
